| Drug Class | Examples to Stop/Minimize | Safer Alternative |
|---|---|---|
| Benzodiazepines | Lorazepam, midazolam, diazepam | Melatonin 3โ5 mg for sleep. Trazodone 25โ50 mg. Non-pharmacologic sleep hygiene. |
| Anticholinergics | Diphenhydramine (Benadryl) -#1 offender on inpatient med lists. Also: hydroxyzine, oxybutynin, promethazine, cyclobenzaprine. | Cetirizine (non-sedating antihistamine). Acetaminophen for pain. Remove diphenhydramine from every PRN order set. |
| Opioids (excess) | High-dose PRN without scheduled non-opioid adjuncts | Scheduled acetaminophen 1g q6h. Add gabapentin for neuropathic. Use opioids for breakthrough only. |
| Antihypertensives (excess) | Home doses continued despite lower inpatient BP โ orthostatic hypotension | Hold/reduce home antihypertensives if SBP < 120 or symptomatic orthostasis. Reassess at discharge. |
| Sedating antipsychotics | Quetiapine, chlorpromazine at high doses | Use lowest effective dose. Time-limit orders. |
| Assessment | What to Check | Action |
|---|---|---|
| Injury survey | Head (laceration, hematoma), hip/pelvis (pain on log-roll), spine (tenderness), extremities | CT head if head strike (mandatory if on anticoagulation). Hip X-ray if hip/groin pain. C-spine if neck pain. |
| Neuro exam | GCS, pupil symmetry, focal deficits, gait (if ambulatory) | Document GCS and neuro status. If on anticoag + head strike โ CT head STAT + repeat at 24h if on warfarin. |
| Vitals | Orthostatic BP/HR (lying โ sitting โ standing) | Drop โฅ 20/10 or HR rise โฅ 30 = orthostatic hypotension โ volume depletion, meds, autonomic dysfunction |
| ECG | Arrhythmia, heart block, QTc prolongation | New arrhythmia โ telemetry. Syncope-related fall โ full syncope workup. |
| Labs | BMP (Na, glucose, Ca), CBC (anemia), INR if on warfarin | Correct metabolic causes. Check drug levels if applicable (digoxin, AEDs). |
| Medication review | Benzos, opioids, antihypertensives, anticholinergics, antipsychotics, diuretics | Deprescribe fall-risk meds. Use Beers Criteria AGS, 2023. Taper, don't abruptly stop. |
| Intervention | Details |
|---|---|
| Bed alarm | For high-risk patients (delirium, impaired mobility, prior fall). NOT physical restraints -restraints increase falls and agitation. |
| Non-slip socks + clear pathway | Remove clutter, ensure call bell within reach, bed in lowest position, nightlight on. |
| Medication reconciliation | Reduce/eliminate: benzodiazepines (#1 contributor), opioids, sedating antihistamines (diphenhydramine), antihypertensives causing orthostasis, anticholinergics. |
| Delirium prevention (HELP protocol) | Orientation aids (clock, calendar), minimize nighttime disruptions, early mobilization, hearing aids/glasses at bedside, avoid unnecessary catheters. |
| PT/OT consult | Gait assessment, strength training, assistive device evaluation. Early mobilization reduces deconditioning. |
| Treat underlying cause | Orthostatic hypotension โ IVF, adjust meds. Syncope โ cardiac workup. Delirium โ find precipitant. Neuropathy โ B12, glucose control. |
| Drug Class | Examples | Mechanism of Fall Risk | Action |
|---|---|---|---|
| Benzodiazepines | Lorazepam, diazepam, alprazolam | Sedation, impaired balance, cognitive slowing | Taper and discontinue. Use melatonin or trazodone for insomnia. |
| Anticholinergics | Diphenhydramine, oxybutynin, cyclobenzaprine | Delirium, sedation, blurred vision, urinary retention | Substitute: cetirizine for allergy, mirabegron for OAB. |
| Opioids | Oxycodone, morphine, tramadol | Sedation, dizziness, impaired coordination | Multimodal pain: acetaminophen, topical NSAIDs, nerve blocks. |
| Antihypertensives | Alpha-blockers (doxazosin), loop diuretics | Orthostatic hypotension, volume depletion | Liberalize BP target in frail elderly (SBP 150 may be acceptable). |
| Antipsychotics | Haloperidol, quetiapine | Sedation, orthostasis, EPS | Avoid for delirium if possible. If needed, use lowest dose ร shortest duration. |
| Hypoglycemics | Sulfonylureas (glipizide), insulin | Hypoglycemia โ syncope โ fall | Liberalize glucose targets in elderly (A1c 7.5โ8.5% acceptable). |
Patient: 84F on apixaban for Afib, found on floor next to bed at 3 AM. Unwitnessed. Denies head strike but cannot recall details. Oriented, no focal deficits. Small forehead hematoma.
Key findings: High-risk fall: elderly + anticoagulation + possible head strike + unreliable history. Intracranial hemorrhage can present delayed in anticoagulated patients, symptoms may appear hours later.
Management:
Teaching point: In anticoagulated patients, CT head should be obtained for any fall with possible head strike, even if the patient looks fine. Subdural hematomas in elderly anticoagulated patients can be insidious, expanding slowly over hours to days before symptoms appear.
Patient: 78M with HTN, BPH, T2DM. Third fall in 2 months. Home meds: amlodipine 10, doxazosin 4 mg, metoprolol 50 BID, trazodone 50 mg QHS. Orthostatic vitals: supine 148/82 โ standing 108/58 with dizziness.
Key findings: Orthostatic hypotension (โฅ 20 mmHg SBP drop or โฅ 10 mmHg DBP drop within 3 min of standing). Multiple contributing medications: doxazosin (alpha-blocker, worst offender), amlodipine, trazodone. Polypharmacy in elderly = falls.
Management:
Teaching point: The #1 intervention for falls is medication review. Deprescribing fall-risk medications prevents more falls than any exercise program or environmental modification. Doxazosin is the classic "stop this drug" answer on falls assessment.
Patient: 82F with osteoporosis (T-score -3.4), fell from standing. Unable to bear weight on left leg. Left leg shortened and externally rotated. XR: left intertrochanteric hip fracture.
Key findings: Hip fracture from low-energy fall, pathologic fracture through osteoporotic bone. Hip fractures in elderly carry 20-30% 1-year mortality. Time to surgery is critical, OR within 24-48h reduces complications and mortality.
Management:
Teaching point: A hip fracture is an orthopedic emergency, not an elective case. Every hour of surgical delay increases morbidity. The fascia iliaca block is a game-changer, it provides excellent pain control without the delirium risk of systemic opioids in elderly patients.
| Parameter | Frequency | Action |
|---|---|---|
| Neuro checks | q4h ร 24h if head strike + anticoag | GCS, pupil reactivity, focal deficits. Decline โ repeat CT head STAT. |
| Repeat CT head | 24h post-fall if on warfarin + head strike | Delayed SDH can develop. Even if initial CT negative. |
| Vitals + orthostatics | Daily until resolved | Orthostatic hypotension โ adjust meds, IVF. |
| Morse Fall Scale | Each shift | Reassess fall risk. Update care plan. |
| Incident report | Immediately | Document fall circumstances, injuries, interventions. Notify family. |
| Parameter | Frequency | Target / Action |
|---|---|---|
| aPTT (heparin drip) | q6h until stable, then q12h | Target aPTT 60โ80 sec (or per institutional protocol). Adjust infusion rate per nomogram. |
| INR (warfarin) | Daily while inpatient, then weekly โ monthly when stable | Target INR 2.0โ3.0. Bridge with heparin x 5 days AND until INR โฅ 2 for 24h before stopping heparin. |
| Platelets (HIT surveillance) | q2โ3 days on heparin (days 4โ14) | HIT: > 50% drop from baseline or platelets < 150K on heparin โ check HIT antibody (PF4/heparin). 4T score to assess probability. If HIT โ stop all heparin, start argatroban or bivalirudin. |
| Creatinine (DOAC dosing) | Baseline and periodically | CrCl determines DOAC eligibility. For VTE: apixaban approved down to CrCl 15 (AMPLIFY excluded < 25, so data weakest 15–25); rivaroxaban avoid < 30; dabigatran avoid < 30; edoxaban avoid < 15. For A-fib (different cutoffs): apixaban dose-reduce to 2.5 mg BID if ≥ 2 of (age ≥ 80, wt ≤ 60, Cr ≥ 1.5); rivaroxaban 15 mg daily if CrCl 15–50. Declining renal function may require switch to warfarin. |
| Bleeding symptoms | Each assessment | GI bleeding (melena, hematochezia), hematuria, gum bleeding, easy bruising, menorrhagia. Any major bleed โ hold anticoagulation, assess need for reversal. |
| Recurrent VTE symptoms | Each assessment + patient education | New leg swelling/pain โ repeat ultrasound. New dyspnea/chest pain โ CTPA. Recurrence on anticoagulation โ consider non-compliance, cancer workup, APS testing. |